Business Description
Cellgentek Co Ltd
ISIN : KR7258250000
Compare
Compare
Traded in other countries / regions
258250.Korea IPO Date
2016-12-13Description
Cellgentek Co Ltd is engaged in provision of information technology services for IT venture companies including computer, IT software development and franchise business. It is also engaged in development of drugs.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.46 | |||||
Debt-to-EBITDA | -17.46 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.24 | |||||
Beneish M-Score | -4.63 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.1 | |||||
3-Year FCF Growth Rate | -1.1 | |||||
3-Year Book Growth Rate | 7.7 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.01 | |||||
9-Day RSI | 0.37 | |||||
14-Day RSI | 2.57 | |||||
6-1 Month Momentum % | -76.19 | |||||
12-1 Month Momentum % | -83.15 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.74 | |||||
Quick Ratio | 0.49 | |||||
Days Inventory | 354.49 | |||||
Days Sales Outstanding | 233.61 | |||||
Days Payable | 19.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.2 | |||||
Shareholder Yield % | 1305.1 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 19.22 | |||||
Operating Margin % | -23.02 | |||||
Net Margin % | -51.23 | |||||
FCF Margin % | -7.85 | |||||
ROE % | -53.64 | |||||
ROA % | -21.42 | |||||
ROIC % | -11.43 | |||||
ROC (Joel Greenblatt) % | -16.09 | |||||
ROCE % | -23.12 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.01 | |||||
PB Ratio | 0.02 | |||||
Price-to-Tangible-Book | 0.02 | |||||
Price-to-Operating-Cash-Flow | 0.13 | |||||
EV-to-EBIT | -3.33 | |||||
EV-to-EBITDA | -17.71 | |||||
EV-to-Revenue | 1.1 | |||||
EV-to-FCF | -14.08 | |||||
Price-to-Net-Current-Asset-Value | 0.11 | |||||
Earnings Yield (Greenblatt) % | -30.03 | |||||
FCF Yield % | -503.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cellgentek Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 14,404.1 | ||
EPS (TTM) (â‚©) | -1636 | ||
Beta | 0.29 | ||
Volatility % | 104.16 | ||
14-Day RSI | 2.57 | ||
14-Day ATR (â‚©) | 46.160653 | ||
20-Day SMA (â‚©) | 519.45 | ||
12-1 Month Momentum % | -83.15 | ||
52-Week Range (â‚©) | 42 - 6220 | ||
Shares Outstanding (Mil) | 4.99 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cellgentek Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cellgentek Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Cellgentek Co Ltd Frequently Asked Questions
What is Cellgentek Co Ltd(XKRX:258250)'s stock price today?
The current price of XKRX:258250 is â‚©45.00. The 52 week high of XKRX:258250 is â‚©6220.00 and 52 week low is â‚©42.00.
When is next earnings date of Cellgentek Co Ltd(XKRX:258250)?
The next earnings date of Cellgentek Co Ltd(XKRX:258250) is .
Does Cellgentek Co Ltd(XKRX:258250) pay dividends? If so, how much?
Cellgentek Co Ltd(XKRX:258250) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |